BABA vs CRL · P/E 20, rev $148.40B vs rev $2.00B
Alibaba Group Holding Ltd (BABA) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported BABA revenue for 2026-03-31 was $148.40B. Net income was $15.02B. Revenue was up 8.1% from 2025-03-31 to 2026-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BABA and CRL stock pages for the full models.
Not investment advice.